Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PINS vs MRNA✓SelectedUSD · MRNAPINS vs MRNA performance historyLatest closeAs of-3.32%11/20
Stock and ETF performance explorer

PINS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-49.2%
MRNA return
+153.9%
Excess return
-203.1%
Maximum drawdown
-65.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.3%-2.2%-1.1%-3.2%
7D-14.7%-12.7%-2.0%-14.2%
30D-28.8%-20.7%-8.2%-28.1%
3M-29.7%+46.3%-76.0%-31.1%
6M-13.2%+305.2%-318.4%-24.1%
YTD-36.9%+561.2%-598.2%-49.4%
1Y-34.2%+772.1%-806.3%-49.6%
3Y-49.2%+147.0%-196.1%-56.2%
All-49.2%+153.9%-203.1%-56.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling